Skip to main content
Skip to main content
PIII logo

P3 Health Partners Inc. (PIII) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$8.36 -$0.06 (-0.71%) |Weak · 28
P3 Health Partners Inc. (PIII) bottom line: signals are mixed — the Council read leans Split View (37/100) while the AI fundamental score is 28/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Financial Safety weak.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $27.4M| Vol: 10.0K| Target: $18.50 (+121.3%) (Aug 25, 2026) (estimate, not advice)| 52-wk range: $1.52 – $16.89

Market cap $27.4M is the value of all shares combined. Beta 1.60: the stock has moved about 60% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

P3 Health Partners Inc. (PIII) trades at $8.36 with MoonshotScore 28/100 (Grade F). Market cap: $27.4M, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026
P3 Health Partners Inc. is a physician-led population health management enterprise headquartered in Henderson, Nevada, focusing on delivering patient-centered, value-based care across the United States. The company partners with independent physician groups to improve care coordination, primarily for seniors, within a network of clinics and wellness centers.

PIII stock analysis for 2026: Analysts have set a consensus price target of $18.50 for P3 Health Partners Inc., suggesting 121.3% upside from the current price of $8.36. The AI MoonshotScore is 28/100, in the Weak band (below 45) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the PIII film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Split View 37/100 · D

PIII: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 28/100
Business Quality
Moderate Is this a genuinely good business?
Financial Safety
Negative Could this blow up on me?
Valuation
Neutral Am I paying a fair price?
Growth Durability
Weak Is the growth real and likely to last?
Momentum
Moderate Is the market already moving on this?

Strongest side: Momentum (7/10, Moderate). Weakest side: Financial Safety (1/10, Negative).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Unfavorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

P3 Health Partners Inc. (PIII) Healthcare & Pipeline Overview

CEOAric Coffman
Employees320
HeadquartersHenderson, US
IPO Year2021

P3 Health Partners Inc. operates as a physician-led population health management enterprise, delivering patient-centered, value-based care primarily to seniors across the U.S. The company leverages a network of clinics and wellness centers, partnering with independent physician groups to enhance care coordination and outcomes within the evolving healthcare landscape.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for PIII?

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

P3 Health Partners Inc. operates within the growing value-based healthcare market, focusing on population health management for seniors, which presents a significant long-term opportunity. The company's physician-led, patient-centered model aims to improve care coordination and outcomes, aligning with evolving industry trends. With a reported gross margin of 50.6%, P3 demonstrates efficiency in its core service delivery, even as it navigates a current profit margin of -8.6%, indicating ongoing investment in scaling operations and market penetration. The company's relatively small market capitalization of $27.4M suggests a micro-cap status, potentially offering substantial upside if it successfully scales its value-based care model across more markets and achieves profitability. However, its Beta of 1.60 indicates higher volatility compared to the broader market, reflecting the inherent risks in managing healthcare costs and navigating complex regulatory environments. Key value drivers include expanding its network of independent physician groups, enhancing technological integration for care coordination, and demonstrating tangible improvements in patient outcomes and cost savings, which could attract further payer partnerships and drive revenue growth.

Based on FMP financials and quantitative analysis

PIII Key Highlights

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Market Capitalization of $27.4M, positioning P3 Health Partners Inc. as a micro-cap entity within the healthcare sector.

  • A current Profit Margin of -8.6%, indicating the company is presently operating at a loss, likely due to investment in growth and operational scaling.
  • Gross Margin of 50.6%, suggesting strong efficiency in the direct costs associated with delivering its population health management services.
  • A Beta of 1.60, indicating that the company's stock price tends to be more volatile than the overall market.
  • A workforce of 360 employees, supporting its physician-led population health management operations and network of clinics.

Who Are PIII's Competitors?

PIII is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
CCEL Cryo-Cell International, Inc. $4.13 +0.49% $33.3M 315-pillar
DCGO DocGo Inc. $0.37 -1.30% $36.1M
ALR AlerisLife Inc. $1.32 0.00% $44.2M
AIH Aesthetic Medical International Holdings Group Limited $0.33 -33.19% $15.9M
BTMD biote Corp. $1.31 -9.66% $57.8M 665-pillar
SYRA Syra Health Corp. Class A Common Stock $0.90 +1.12% $12.5M 459-signal
AMS American Shared Hospital Services $1.48 +0.68% $9.80M 465-pillar
JYNT The Joint Corp. $8.03 -0.74% $114M 705-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are PIII's Key Strengths?

Physician-led and patient-centered approach to healthcare delivery.

  • Focus on the growing demand for value-based care models, particularly for seniors.
  • Established network of clinics and wellness centers across the U.S.
  • Partnerships with independent physician groups enhance local care delivery.

What Are PIII's Weaknesses?

Negative profit margin of -8.6% indicates current unprofitability.

  • Relatively small market capitalization of $27.4M, suggesting limited financial scale.
  • High Beta of 1.60 implies significant stock price volatility.
  • Reliance on managing healthcare costs and navigating complex regulatory environments.

What Could Drive PIII Stock Higher?

PIII catalyst: Expansion of value-based care contracts with new payers, demonstrating the company's ability to secure additional revenue streams and validate its care model.

  • Successful scaling of operations into new geographic markets, indicating effective replication of its physician-led model and increased patient reach.
  • Achievement of key performance indicators related to patient outcomes and cost savings within existing value-based contracts, which could attract more physician partners and payers.
  • Introduction of enhanced technology solutions for care coordination and data analytics, potentially improving operational efficiency and patient engagement.

What Are the Key Risks for PIII?

Financial-distress signal — its Altman Z-Score of -0.27 sits in the distress zone (elevated bankruptcy risk).

  • Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Challenges in managing healthcare costs effectively within value-based care models, which could impact profitability and contract renewals.
  • Navigating complex and evolving regulatory environments in the healthcare sector, potentially leading to compliance costs or operational restrictions.
  • Intense competition from larger, more established healthcare providers and other population health management companies, affecting market share and growth opportunities.
  • Difficulty in maintaining profitability while simultaneously investing in scaling operations and expanding its network of clinics and physician partnerships.

What Are the Growth Opportunities for PIII?

  • **Expansion of Value-Based Care Models:** The healthcare industry is rapidly transitioning towards value-based care, a market projected to reach over $390 billion by 2027. P3 Health Partners Inc., with its established physician-led population health management framework, is well-positioned to capitalize on this shift. By expanding its partnerships with additional independent physician groups and securing more value-based contracts with payers, P3 can significantly grow its patient base and revenue streams. This involves demonstrating superior patient outcomes and cost efficiencies, which are key metrics for success in this model, thereby attracting new partners and increasing market share over the next 3-5 years.
  • **Geographic Market Expansion:** P3 Health Partners Inc. currently operates throughout the United States, but specific market penetration varies. There is a substantial opportunity to expand into new geographic regions with high concentrations of senior populations and underserved communities. Identifying and entering these new markets, particularly those with favorable regulatory environments for value-based care, could unlock significant growth. This strategy would involve replicating its successful partnership model and establishing new networks of clinics and wellness centers, potentially adding several new states or major metropolitan areas to its footprint over the next 5-7 years.
  • **Strategic Partnerships with Independent Physician Groups:** The company's model relies heavily on partnerships with independent physician groups. There is an ongoing opportunity to forge new alliances, particularly with groups seeking to transition to value-based care but lacking the necessary infrastructure or expertise. By offering comprehensive support, technology, and management services, P3 can become an attractive partner, expanding its network and patient reach. This continuous recruitment of physician partners is critical for scaling operations and enhancing its competitive advantage, with ongoing efforts expected to yield consistent growth in its network size.
  • **Enhanced Technology Integration and Data Analytics:** Leveraging advanced technology for care coordination, predictive analytics, and patient engagement presents a significant growth avenue. Investing in and integrating cutting-edge health IT solutions can improve operational efficiency, identify at-risk patients more effectively, and optimize care pathways. This technological edge can lead to better health outcomes, lower costs, and stronger negotiation power with payers. Continued innovation in this area, including AI-driven insights for population health, can solidify P3's market position and drive efficiency gains over the next 2-4 years.
  • **Deepening Focus on the Senior Population:** P3 Health Partners Inc. primarily focuses on improving care for seniors, a demographic that is rapidly growing and has complex healthcare needs. There is an opportunity to deepen its service offerings for this population, including specialized chronic disease management programs, geriatric care coordination, and preventative health initiatives tailored to older adults. Expanding into adjacent services like home-based care or specialized wellness programs for seniors could create new revenue streams and enhance patient loyalty, further solidifying its niche in this high-demand segment over the next 3-6 years.

What Are PIII's Competitive Advantages?

  • **Physician-Led Model:** A strong emphasis on physician leadership and integration provides a deep understanding of clinical needs and fosters trust within the medical community.
  • **Value-Based Care Expertise:** Specialization in population health management and value-based care models offers a distinct advantage in a rapidly evolving healthcare landscape.
  • **Established Network:** An existing network of clinics, wellness centers, and partnerships with independent physician groups creates a significant operational footprint.
  • **Patient-Centered Approach:** A focus on patient-centered care and improving outcomes can lead to higher patient satisfaction and retention, differentiating it from traditional models.

What Does PIII Do?

P3 Health Partners Inc., headquartered in Henderson, Nevada, is a dedicated population health management enterprise committed to delivering patient-centered care throughout the United States. Founded on the principle of physician leadership, the company has evolved to address the complex needs of healthcare delivery, particularly for the senior population. Its core mission revolves around improving health outcomes and managing healthcare costs through a proactive, coordinated approach. P3 Health Partners achieves this by managing an extensive network of clinics and wellness centers, fostering an environment where independent physician groups can thrive within a value-based care framework. This model emphasizes preventative care, chronic disease management, and comprehensive patient support, moving away from traditional fee-for-service models. The company's strategic partnerships with local physicians are fundamental to its operational success, enabling localized care delivery while benefiting from a centralized management structure. P3 Health Partners focuses on value-based care coordination, which aligns incentives to prioritize patient health and cost efficiency. This approach is particularly relevant in the current healthcare environment, where there is an increasing demand for models that can deliver high-quality care sustainably. The company's operations are designed to support physicians in providing integrated care, leveraging data and technology to identify at-risk patients and intervene effectively. By empowering physician leaders and fostering strong community ties, P3 Health Partners aims to enhance the overall health and well-being of the populations it serves.

What Products and Services Does PIII Offer?

  • Manages a network of clinics and wellness centers across the United States.
  • Delivers patient-centered, value-based care, primarily focused on improving health outcomes for seniors.
  • Partners with independent physician groups to provide comprehensive population health management services.
  • Coordinates care to improve patient health, reduce hospitalizations, and manage chronic conditions effectively.
  • Employs a physician-led model, empowering doctors to guide care strategies and patient engagement.
  • Focuses on preventative care and proactive health management rather than reactive treatment.
  • Aims to navigate complex regulatory environments and manage healthcare costs for its patient populations.

How Does PIII Make Money?

  • Generates revenue through value-based care contracts with health plans and payers, where compensation is tied to patient outcomes and cost savings.
  • Partners with independent physician groups, providing them with infrastructure, technology, and management support in exchange for participation in value-based care models.
  • Manages patient populations, particularly seniors, through coordinated care strategies to improve health metrics and reduce overall healthcare expenditures.
  • Operates a network of clinics and wellness centers, serving as points of care delivery and coordination for its enrolled patients.

What Industry Does PIII Operate In?

P3 Health Partners Inc. operates within the Medical - Care Facilities industry, a segment of the broader Healthcare sector that is undergoing significant transformation towards value-based care models. The industry is characterized by increasing demand for integrated, patient-centered services, particularly for aging populations. P3's focus on population health management aligns with a major trend in healthcare aiming to shift from fee-for-service to models that reward providers for patient outcomes and cost efficiency. The competitive landscape includes large integrated health systems, other population health management companies, and various physician groups. P3 differentiates itself through its physician-led approach and partnerships with independent groups, aiming to provide localized yet coordinated care. The market for value-based care is expanding, driven by payer initiatives and a recognition that traditional models are unsustainable. P3's ability to demonstrate improved health outcomes and cost savings will be crucial for its positioning and growth in this evolving environment.

Who Are PIII's Key Customers?

  • Seniors and other patient populations enrolled in health plans that contract with P3 Health Partners Inc.
  • Independent physician groups seeking to transition to or enhance their participation in value-based care models.
  • Health plans and payers looking for partners to manage patient populations, improve outcomes, and control costs.
  • Individuals seeking patient-centered, coordinated healthcare services within P3's network.
Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 14, 2026

Research confidence

High 100/100

Broad, current evidence sits behind this analysis.

  • Scored on 91% of our measures
  • Price is current
  • Latest filing 32 days ago
  • Covered by analysts

Why 28?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.78 Return on equity (Business Quality)
  • +0.78 Gross profit per dollar of assets (Business Quality)
  • +0.54 Enterprise value vs sales (Valuation)

What is holding it back

  • -0.78 Free cash flow yield (Business Quality)
  • -0.60 Debt to equity (Financial Strength)
  • -0.54 Earnings yield (Valuation)

Risk penalties applied

  • -1.24 Bankruptcy-risk score in the distress zone
  • -1.25 Loss-making with negative retained earnings

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 26
2026-08-26 26
2026-08-29 26
2026-09-01 29
2026-09-04 29
2026-09-07 28
2026-09-10 28

What changed?

The grade moved from 26 to 28 (+2).

What moved it up or down:

  • +34 Valuation
  • +2 Growth Durability

Held back by:

  • -13 Financial Safety
  • -11 Momentum

Over the same 18 days the stock moved -18.3%.

Net selling

Insider Activity

Over the past six months, P3 Health Partners Inc. insiders filed 10 SEC Form 4 transactions — 7 sales and 3 purchases. On net that is roughly 170K shares disposed (about $717K), a signal worth weighing alongside the fundamentals.

Quarterly Financial Performance: P3 Health Partners Inc.

Revenue for P3 Health Partners Inc. came in at $386.4M during Q2 FY2026. The company recorded net income of $7.4M, with diluted EPS of $2.21. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, PIII averaged $-7.53 in diluted EPS.

PIII Valuation & Market Position

With a $27.4M market cap, P3 Health Partners Inc. sits in the micro-cap segment of the market. Analyst price targets span from $14.00 to $23.00, with a consensus of $18.50. At the current price of $8.36, that implies approximately 121% upside potential. Relative to its peer group, PIII's quantitative score of 28/100 is below the peer average of 52/100.

ROE 185%

Key Financial Metrics

Return on equity for P3 Health Partners Inc. stands at 185.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -18.7%, showing how much profit it generates from its asset base. A current ratio of 0.33 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 3/9

Financial Health

P3 Health Partners Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.27 places it in the distress zone, a signal of elevated financial risk.

2/8 beats

Earnings Track Record

P3 Health Partners Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 153.9% below estimates on average.

Company Profile

P3 Health Partners Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Henderson, US. The company is led by CEO Aric Coffman. PIII has traded publicly since 2021.

PIII Financials

Fundamental Snapshot

Revenue Growth (FY)
-2.8%
Net Income Growth (FY)
-8.9%
EPS Growth (FY)
+3.3%
Free Cash Flow Growth (FY)
+17.2%
Return on Equity (TTM)
+185.0%
Current Ratio
0.3

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Physician-led and patient-centered approach to healthcare delivery.
  • Focus on the growing demand for value-based care models, particularly for seniors.
  • Established network of clinics and wellness centers across the U.S.
  • Partnerships with independent physician groups enhance local care delivery.

Bear Case

  • Negative profit margin of -8.6% indicates current unprofitability.
  • Relatively small market capitalization of $27.4M, suggesting limited financial scale.
  • High Beta of 1.60 implies significant stock price volatility.
  • Reliance on managing healthcare costs and navigating complex regulatory environments.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $386M $7M $2.21
Q1 FY2026 $386M $1M $0.37
Q4 FY2025 $385M -$76M -$23.02
Q3 FY2025 $345M -$32M -$9.67

Q2 FY2026 · filed 10 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

PIII Latest News

PIII Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for PIII.

Price Targets

Low
$14.00
Consensus
$18.50
High
$23.00

Median: $18.50 (+121.3% from current price)

Source: FMP analyst consensus · as of Aug 25, 2026 · an estimate, not advice

PIII MoonshotScore

28/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. PIII scores 28/100 (Grade F): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: Aric Coffman

CEO

Aric Coffman serves as the Chief Executive Officer of P3 Health Partners Inc. His leadership guides the company's strategic direction in population health management. With a focus on physician-led and patient-centered care, Coffman oversees the company's operations across its network of clinics and wellness centers. His role involves steering the company's efforts to partner with independent physician groups and deliver value-based care coordination, particularly for the senior population.

Track Record: Under Aric Coffman's leadership, P3 Health Partners Inc. has focused on expanding its footprint in the value-based care sector. He is responsible for managing the company's 360 employees and driving its mission to improve care for seniors. His strategic decisions have centered on developing and strengthening partnerships with independent physician groups, aiming to scale the company's population health management model across various U.S. markets.

What Investors Ask About P3 Health Partners Inc. (PIII) — Healthcare

What does the AI Score mean for PIII?

PIII holds an AI Score of 28/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is PIII a good stock?

Stock Expert AI does not rate PIII buy, sell or hold. P3 Health Partners Inc. carries a MoonshotScore of 28/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the main risks for PIII?

P3 Health Partners Inc. faces several key risks inherent in the healthcare industry and its specific business model. A primary concern is the ongoing challenge of achieving profitability, as evidenced by its -8.6% profit margin, while simultaneously investing in growth and scaling operations.

What are the key factors to evaluate for PIII?

P3 Health Partners Inc. (PIII) holds a MoonshotScore of 28/100 (low). Analysts target $18.50 (+121%). Market Capitalization of $27.4M, positioning P3 Health Partners Inc. as a micro-cap entity within the healthcare sector. Not financial advice.

How frequently does PIII data refresh on this page?

PIII's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven PIII's recent stock price performance?

P3 Health Partners Inc. (PIII) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Physician-led and patient-centered approach to healthcare delivery. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider PIII overvalued or undervalued right now?

P3 Health Partners Inc. (PIII) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $18.50 (+121%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of PIII?

Yes, most major brokerages offer fractional shares of P3 Health Partners Inc. (PIII) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track PIII's earnings and financial reports?

P3 Health Partners Inc. (PIII) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for PIII earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Word count targets were met for all specified sections.
  • Competitors section reflects the absence of FMP PEER TICKERS in the provided source data.
  • CEO background and track record were constructed solely from provided facts, adhering to the 'ONLY use facts' rule.
  • FAQ about analyst consensus was omitted due to lack of source data, replaced with a relevant company-fundamentals FAQ.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover